Which has the lower trailing P/E, AZN or LLY?

AZN has the lower trailing P/E: AZN trades at 24.05 and LLY at 37.42. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AZN or LLY?

Over the past five years, LLY grew revenue faster — AZN at a 15.76% CAGR versus LLY at 24.42%.

Does AZN or LLY pay a bigger dividend?

AZN yields 2.02% and LLY yields 0.60% based on trailing dividends and the latest price.

Is AZN or LLY more profitable?

LLY runs the higher net margin — AZN at 17.02% versus LLY at 33.53%.

How have AZN and LLY total returns compared?

Over the past 10 years, AZN delivered 12.85% and LLY delivered 32.58% annualized total return. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Eli Lilly and Company (LLY)

A side-by-side comparison of AstraZeneca PLC and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

AZN

AstraZeneca PLC

$248.40B

$160.17HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

LLY

Eli Lilly and Company

$1.05T

$1,115.25HealthcareDelayed quote: Sep 11, 2026, 3:59 PM EDT

Total return — AZN vs LLY

growth of $100 · dividends reinvested · last 10y

AZN +228.1% (+12.6%/yr)LLY +1566.6% (+32.5%/yr)LLY compounded faster over this window

Log scale — wide-divergence pair

AZN LLY

AZN vs LLY: by the numbers

•LLY is the larger company ($1.05T vs $248.40B market cap).
•AZN trades at the lower trailing earnings multiple (24.05 vs 37.42 P/E), one valuation lens rather than an overall verdict.
•LLY converts more revenue to profit (33.53% vs 17.02% net margin).
•LLY grew revenue faster over the past five years (24.42% vs 15.76% CAGR).
•AZN pays the higher dividend yield (2.02% vs 0.60%).

Metrics side by side

Valuation

Metric	AZN	LLY
P/E ratio	24.05	37.42
Forward P/E	15.64	30.64
P/S ratio	4.05	13.18
P/B ratio	4.94	31.00
EV / EBITDA	13.56	29.91
FCF yield	3.52%	1.91%

Profitability

Metric	AZN	LLY
Gross margin	81.88%	84.01%
Operating margin	22.77%	43.92%
Net margin	17.02%	33.53%
ROE	20.79%	78.84%
ROIC	12.83%	27.38%

Dividends

Metric	AZN	LLY
Dividend yield	2.02%	0.60%
Payout ratio	48.50%	22.45%

Growth (annualized)

Metric	AZN	LLY
Revenue CAGR (5Y)	15.76%	24.42%
EPS CAGR (5Y)	22.02%	28.88%
FCF CAGR (5Y)	14.53%	32.91%
Total return CAGR (5Y)	9.46%	37.46%

Frequently asked

Which has the lower trailing P/E, AZN or LLY?: AZN has the lower trailing P/E: AZN trades at 24.05 and LLY at 37.42. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AZN or LLY?: Over the past five years, LLY grew revenue faster — AZN at a 15.76% CAGR versus LLY at 24.42%.
Does AZN or LLY pay a bigger dividend?: AZN yields 2.02% and LLY yields 0.60% based on trailing dividends and the latest price.
Is AZN or LLY more profitable?: LLY runs the higher net margin — AZN at 17.02% versus LLY at 33.53%.
How have AZN and LLY total returns compared?: Over the past 10 years, AZN delivered 12.85% and LLY delivered 32.58% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full LLY analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Eli Lilly P/E ratio AstraZeneca dividend yield Eli Lilly dividend yield AstraZeneca ROE Eli Lilly ROE AstraZeneca operating margin Eli Lilly operating margin AstraZeneca revenue growth Eli Lilly revenue growth AstraZeneca free cash flow Eli Lilly free cash flow

AstraZeneca & Eli Lilly appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.